A drugmaker is pulling a lot of thyroid tablets from the market nationwide because testing confirmed the pills may contain more hormone than the label says, an unusual reversal of the more familiar pattern in which recalled thyroid medicine turns out to be too weak.
Vitruvias Therapeutics, based in Auburn, Alabama, is recalling one lot of Thyroid Tablets, USP 30 mg to the consumer level. The affected lot is number 504950, carrying national drug code 69680-166-00 and an expiration date of September 30, 2026. The company issued the announcement on August 21, 2026, and the FDA published it three days later. The agency posts company recall announcements as a public service without endorsing the product or the firm.
